Literature DB >> 27020558

Multiple sclerosis: Repurposing dopaminergic drugs for MS--the evidence mounts.

Franca Marino1, Marco Cosentino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27020558     DOI： 10.1038/nrneurol.2016.33

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

Review 1.  Immunopathogenesis and immunotherapy of multiple sclerosis.

Authors:  Bernhard Hemmer; Stefan Nessler; Dun Zhou; Bernd Kieseier; Hans-Peter Hartung
Journal:  Nat Clin Pract Neurol       Date:  2006-04

2.  Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

Authors:  Marco Cosentino; Anna Maria Fietta; Marco Ferrari; Emanuela Rasini; Raffaella Bombelli; Elena Carcano; Federica Saporiti; Federica Meloni; Franca Marino; Sergio Lecchini
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

Review 3.  Disturbed regulatory T cell homeostasis in multiple sclerosis.

Authors:  Koen Venken; Niels Hellings; Roland Liblau; Piet Stinissen
Journal:  Trends Mol Med       Date:  2010-02       Impact factor: 11.951

Review 4.  The physiology, signaling, and pharmacology of dopamine receptors.

Authors:  Jean-Martin Beaulieu; Raul R Gainetdinov
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 5.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

Review 6.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

7.  The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.

Authors:  Mikhail Melnikov; Olga Belousova; Vladimir Murugin; Мikhail Pashenkov; Alexey Boyко
Journal:  J Neuroimmunol       Date:  2016-02-04       Impact factor: 3.478

Review 8.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

9.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.

Authors:  John S Tzartos; Manuel A Friese; Matthew J Craner; Jackie Palace; Jia Newcombe; Margaret M Esiri; Lars Fugger
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307
  9 in total
  15 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 2.  Dopamine, T cells and multiple sclerosis (MS).

Authors:  Mia Levite; Franca Marino; Marco Cosentino
Journal:  J Neural Transm (Vienna)       Date:  2017-03-10       Impact factor: 3.575

Review 3.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

Review 4.  Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.

Authors:  Mikhail Melnikov; Vladimir Rogovskii; Alexey Boykо; Mikhail Pashenkov
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

Review 5.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

6.  Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.

Authors:  Md Ashraf-Uz-Zaman; Guangchen Ji; Dalton Tidwell; Linda Yin; Smathorn Thakolwiboon; Jie Pan; Riley Junell; Zach Griffin; Sadisna Shahi; Derek Barthels; Md Sanaullah Sajib; Paul C Trippier; Constantinos M Mikelis; Hiranmoy Das; Mirla Avila; Volker Neugebauer; Nadezhda A German
Journal:  ACS Chem Neurosci       Date:  2022-01-03       Impact factor: 5.780

Review 7.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

8.  Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells.

Authors:  Xuemei Qiu; Qingqing Guo; Xue Liu; Hui Luo; Danping Fan; Yongqi Deng; Hua Cui; Cheng Lu; Ge Zhang; Xiaojuan He; Aiping Lu
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

9.  Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.

Authors:  Carolina Prado; Michela Gaiazzi; Hugo González; Valentina Ugalde; Alicia Figueroa; Francisco J Osorio-Barrios; Ernesto López; Alvaro Lladser; Emanuela Rasini; Franca Marino; Mauro Zaffaroni; Marco Cosentino; Rodrigo Pacheco
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

10.  Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis.

Authors:  Rufeng Xue; Huimin Zhang; Jun Pan; Zhiwei Du; Wenjie Zhou; Zhi Zhang; Zhigang Tian; Rongbin Zhou; Li Bai
Journal:  Front Immunol       Date:  2018-10-17       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.